Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence
Metadatos
Mostrar el registro completo del ítemEditorial
Springer Nature
Fecha
2018-05-22Referencia bibliográfica
Vera-Ramirez, L., Vodnala, S.K., Nini, R. et al. Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence. Nat Commun 9, 1944 (2018). https://doi.org/10.1038/s41467-018-04070-6
Patrocinador
Intramural Research Program of the NCI, NIH; NIH HPC Biowulf cluster (http://hpc.nih.gov); Andalusian Regional Ministry of Health—Fundacion Progreso y SaludResumen
Cancer recurrence after initial diagnosis and treatment is a major cause of breast cancer (BC)
mortality, which results from the metastatic outbreak of dormant tumour cells. Alterations in
the tumour microenvironment can trigger signalling pathways in dormant cells leading to
their proliferation. However, processes involved in the initial and the long-term survival of
disseminated dormant BC cells remain largely unknown. Here we show that autophagy is a
critical mechanism for the survival of disseminated dormant BC cells. Pharmacologic or
genetic inhibition of autophagy in dormant BC cells results in significantly decreased cell
survival and metastatic burden in mouse and human 3D in vitro and in vivo preclinical models
of dormancy. In vivo experiments identify autophagy gene autophagy-related 7 (ATG7) to be
essential for autophagy activation. Mechanistically, inhibition of the autophagic flux in
dormant BC cells leads to the accumulation of damaged mitochondria and reactive oxygen
species (ROS), resulting in cell apoptosis.





